Enhanced mammary progesterone receptor-A isoform activity in the promotion of mammary tumor progression by dietary soy in rats.
Dietary contribution to breast cancer risk, recurrence, and progression remains incompletely understood. Increased consumption of soy and soy isoflavones is associated with reduced mammary cancer susceptibility in women and in rodent models of carcinogenesis. In rats treated with N-methyl-N-nitrosourea, dietary intake of soy protein isolate (SPI) reduced mammary tumor occurrence but increased incidence of more invasive tumors in tumored rats, relative to the control diet casein. Here we evaluated whether mammary tumor progression in tumor-bearing rats lifetime exposed to SPI is associated with deregulated progesterone receptor (PR) isoform expression. In histologically normal mammary glands of rats with invasive ductal carcinoma lesions, PR-A protein levels were higher for SPI- than casein-fed rats, whereas PR-B was undetectable for both groups. Increased mammary PR-A expression was associated with higher transforming growth factor-beta1, stanniocalcin-1, and CD44 transcript levels; lower E-cadherin and estrogen receptor-alpha expression; and reduced apoptotic status in ductal epithelium. Serum progesterone (ng/ml) (CAS: 25.94 +/- 3.81; SPI: 13.19 +/- 2.32) and estradiol (pg/ml) (CAS: 27.9 +/- 4.49; SPI: 68.48 +/- 23.87) levels differed with diet. However, sera from rats of both diet groups displayed comparable mammosphere-forming efficiency in human MCF-7 cells. Thus, soy-rich diets may influence the development of more aggressive tumors by enhancing PR-A-dependent signaling in premalignant breast tissues.
Dave
Bhuvanesh
B
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, and Arkansas Children's Nutrition Center, Little Rock, AR 72202, USA.
Wynne
Rebecca
R
Su
Ying
Y
Korourian
Soheila
S
Chang
Jenny C
JC
Simmen
Rosalia C M
RC
D000818:Animals; D018270:Carcinoma, Ductal, Breast / Q000209:etiology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000209:etiology; D045744:Cell Line, Tumor; D018450:Disease Progression; D005260:Female; D019833:Genistein / Q000008:administration & dosage*; D006801:Humans; D018960:Hyaluronan Receptors / Q000235:genetics; D007529:Isoflavones / Q000008:administration & dosage*; D008321:Mammary Glands, Animal / Q000737:chemistry; D008325:Mammary Neoplasms, Experimental / Q000737:chemistry / Q000209:etiology*; D051381:Rats; D011980:Receptors, Progesterone / Q000032:analysis / Q000502:physiology*; D053773:Transforming Growth Factor beta1 / Q000235:genetics
D018960:Hyaluronan Receptors; D007529:Isoflavones; D011980:Receptors, Progesterone; D053773:Transforming Growth Factor beta1; C101118:progesterone receptor A; C004742:daidzein; D019833:Genistein